Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.550
-0.020 (-1.27%)
Dec 5, 2025, 4:00 PM EST - Market closed
Autolus Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Autolus Therapeutics stock have an average target of 8.33, with a low estimate of 5.00 and a high estimate of 10. The average target predicts an increase of 437.42% from the current stock price of 1.55.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 3, 2025.
Analyst Ratings
The average analyst rating for Autolus Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +545.16% | Nov 3, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +545.16% | Oct 20, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +222.58% | Aug 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +545.16% | Jul 21, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +545.16% | Jun 12, 2025 |
Financial Forecast
Revenue This Year
76.72M
from 10.12M
Increased by 658.11%
Revenue Next Year
146.80M
from 76.72M
Increased by 91.34%
EPS This Year
-0.98
from -0.86
EPS Next Year
-0.78
from -0.98
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 84.0M | 188.3M | ||||
| Avg | 76.7M | 146.8M | ||||
| Low | 70.0M | 107.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 730.0% | 145.4% | ||||
| Avg | 658.1% | 91.3% | ||||
| Low | 591.9% | 40.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.87 | -0.53 | ||||
| Avg | -0.98 | -0.78 | ||||
| Low | -1.04 | -1.02 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.